NRXN1
Basic information
Region (hg38): 2:49918503-51225575
Links
Phenotypes
GenCC
Source:
- schizophrenia (Limited), mode of inheritance: Unknown
- autism (Moderate), mode of inheritance: AD
- Pitt-Hopkins-like syndrome 2 (Moderate), mode of inheritance: AR
- chromosome 2p16.3 deletion syndrome (Strong), mode of inheritance: AD
- Pitt-Hopkins-like syndrome 2 (Strong), mode of inheritance: AR
- complex neurodevelopmental disorder (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Schizophrenia 17; Pitt-Hopkins-like syndrome 2 | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic | 18369103; 17989066; 18945720; 19896112; 21424692 |
ClinVar
This is a list of variants' phenotypes submitted to
- Pitt-Hopkins-like syndrome 2 (25 variants)
- not provided (4 variants)
- Autism spectrum disorder (2 variants)
- Intellectual disability (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NRXN1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 21 | 421 | 448 | |||
missense | 884 | 891 | ||||
nonsense | 10 | 20 | ||||
start loss | 3 | |||||
frameshift | 18 | 30 | ||||
inframe indel | 10 | 19 | ||||
splice donor/acceptor (+/-2bp) | 13 | |||||
splice region | 34 | 51 | 85 | |||
non coding | 96 | 206 | 107 | 411 | ||
Total | 31 | 24 | 1024 | 640 | 116 |
Highest pathogenic variant AF is 0.00000658
Variants in NRXN1
This is a list of pathogenic ClinVar variants found in the NRXN1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-49918552-A-ATTGTC | Pitt-Hopkins-like syndrome | Uncertain significance (Jun 14, 2016) | ||
2-49918598-A-T | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 12, 2018) | ||
2-49918666-A-C | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 13, 2018) | ||
2-49918740-G-A | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 12, 2018) | ||
2-49918758-T-G | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 13, 2018) | ||
2-49918821-G-A | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 13, 2018) | ||
2-49919066-C-T | Pitt-Hopkins-like syndrome 2 | Benign (Jan 13, 2018) | ||
2-49919109-A-G | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 12, 2018) | ||
2-49919157-T-C | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 12, 2018) | ||
2-49919178-T-C | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 13, 2018) | ||
2-49919199-C-G | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 13, 2018) | ||
2-49919268-T-TCTAA | Pitt-Hopkins-like syndrome | Uncertain significance (Jun 14, 2016) | ||
2-49919315-T-G | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 13, 2018) | ||
2-49919409-G-A | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 13, 2018) | ||
2-49919430-T-C | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 13, 2018) | ||
2-49919433-C-G | Pitt-Hopkins-like syndrome 2 | Benign (Jan 13, 2018) | ||
2-49919554-A-AATC | Pitt-Hopkins-like syndrome | Uncertain significance (Jun 14, 2016) | ||
2-49919558-T-C | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 13, 2018) | ||
2-49919559-TA-T | Pitt-Hopkins-like syndrome | Uncertain significance (Jun 14, 2016) | ||
2-49919559-T-TA | Pitt-Hopkins-like syndrome | Uncertain significance (Jun 14, 2016) | ||
2-49919567-A-G | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 12, 2018) | ||
2-49919571-C-T | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 12, 2018) | ||
2-49919572-C-T | Pitt-Hopkins-like syndrome 2 | Benign (Jan 13, 2018) | ||
2-49919646-G-C | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 12, 2018) | ||
2-49919658-G-T | Pitt-Hopkins-like syndrome 2 | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NRXN1 | protein_coding | protein_coding | ENST00000404971 | 23 | 1114032 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000361 | 125731 | 0 | 17 | 125748 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.56 | 681 | 897 | 0.759 | 0.0000541 | 10084 |
Missense in Polyphen | 212 | 368.05 | 0.57601 | 4246 | ||
Synonymous | -3.35 | 451 | 369 | 1.22 | 0.0000253 | 3017 |
Loss of Function | 6.44 | 10 | 66.8 | 0.150 | 0.00000378 | 796 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000178 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000803 | 0.0000703 |
Middle Eastern | 0.000178 | 0.000163 |
South Asian | 0.000138 | 0.000131 |
Other | 0.000199 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Neuronal cell surface protein that may be involved in cell recognition and cell adhesion by forming intracellular junctions through binding to neuroligins. May play a role in formation or maintenance of synaptic junctions. May mediate intracellular signaling. May play a role in angiogenesis (By similarity). {ECO:0000250}.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);Extracellular matrix organization;Neuronal System;Neurexins and neuroligins;Non-integrin membrane-ECM interactions;Protein-protein interactions at synapses
(Consensus)
Intolerance Scores
- loftool
- 0.297
- rvis_EVS
- -1.79
- rvis_percentile_EVS
- 2.25
Haploinsufficiency Scores
- pHI
- 0.0902
- hipred
- Y
- hipred_score
- 0.707
- ghis
- 0.646
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.909
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nrxn1
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; immune system phenotype;
Zebrafish Information Network
- Gene name
- nrxn1a
- Affected structure
- caudal vein plexus
- Phenotype tag
- abnormal
- Phenotype quality
- malformed
Gene ontology
- Biological process
- neuron cell-cell adhesion;chemical synaptic transmission;neurotransmitter secretion;axon guidance;synapse assembly;learning;adult behavior;social behavior;vocal learning;neuromuscular process controlling balance;positive regulation of synapse assembly;positive regulation of synaptic transmission, glutamatergic;prepulse inhibition;vocalization behavior;positive regulation of synapse maturation;postsynaptic membrane assembly;gephyrin clustering involved in postsynaptic density assembly;neuroligin clustering involved in postsynaptic membrane assembly;postsynaptic density protein 95 clustering;regulation of synaptic vesicle cycle;regulation of postsynaptic density assembly;trans-synaptic signaling by endocannabinoid;synaptic membrane adhesion;regulation of presynapse assembly;positive regulation of excitatory postsynaptic potential;regulation of grooming behavior
- Cellular component
- nucleolus;endoplasmic reticulum;plasma membrane;integral component of plasma membrane;cell surface;cell junction;nuclear membrane;vesicle;protein-containing complex;presynaptic membrane;neuronal cell body;Schaffer collateral - CA1 synapse;glutamatergic synapse;GABA-ergic synapse;integral component of presynaptic active zone membrane
- Molecular function
- calcium channel regulator activity;calcium ion binding;protein binding;acetylcholine receptor binding;signaling receptor activity;cell adhesion molecule binding;neuroligin family protein binding